Osteoarthritis Trial, Recruiting NCT07104279 Sponsor: Zimmer Biomet Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07104279
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are at least 18 years old and your bones have finished growing
  • Your doctor believes you are physically and mentally able to follow the study's requirements, including attending all scheduled visits
  • You (or your legal representative) are willing and able to review and sign a consent form agreeing to take part
  • Regardless of the study, your doctor has already determined you need a first-time total hip replacement or partial hip replacement (hemi-arthroplasty) due to at least one of the following: significant joint damage from arthritis or rheumatic disease, a recent fracture of the hip bone or femoral neck, or bone tissue death (loss of blood supply) in the hip joint

Who may not be able to join:

  • You have previously had a hip replacement that needs to be replaced or revised
  • You have an active infection, whether in the hip area or anywhere else in the body
  • You have serious muscle, nerve, or blood vessel problems in the affected limb(s)
  • There is not enough bone above or below the hip joint to securely hold the implant in place
  • The muscles or ligaments around the joint are completely or partially missing
  • You have another health condition that could affect how well the implant works
  • You have a known allergy to the materials used in the implant, especially metals such as cobalt, chromium, or nickel
  • You have a bone tumor or cyst in the area where the implant would be placed
  • Your doctor believes participating in the study would put you at unnecessary risk or affect the results
  • You are currently in prison, known to be pregnant, unable to understand what taking part in the study means, or have a known substance abuse problem

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hillary Overholser, Zimmer Biomet

Phone: 980-259-2813

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zimmer Biomet
Registry
ClinicalTrials.gov
Start date
13 October 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

2 Year Survivorship

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov